Occudo Quantitative Strategies LP Trims Stock Position in Genpact Limited (NYSE:G)

Occudo Quantitative Strategies LP cut its stake in shares of Genpact Limited (NYSE:G - Free Report) by 64.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,193 shares of the business services provider's stock after selling 25,401 shares during the quarter. Occudo Quantitative Strategies LP's holdings in Genpact were worth $610,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. Coppell Advisory Solutions LLC boosted its holdings in shares of Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after acquiring an additional 503 shares during the last quarter. SRH Advisors LLC acquired a new position in Genpact during the fourth quarter valued at $26,000. Atlas Capital Advisors Inc. boosted its holdings in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the last quarter. Manchester Capital Management LLC acquired a new stake in Genpact during the 4th quarter worth about $38,000. Finally, GeoWealth Management LLC raised its stake in shares of Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after buying an additional 583 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Genpact Price Performance

Shares of G stock traded up $0.41 during trading hours on Friday, hitting $44.28. 2,286,869 shares of the company's stock were exchanged, compared to its average volume of 1,368,521. Genpact Limited has a fifty-two week low of $30.38 and a fifty-two week high of $56.76. The firm has a market cap of $7.74 billion, a P/E ratio of 15.59, a P/E/G ratio of 1.84 and a beta of 1.02. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $48.02 and a two-hundred day moving average of $47.19.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The firm's revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.73 EPS. Sell-side analysts forecast that Genpact Limited will post 3.21 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Robert W. Baird lowered their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC dropped their price target on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a research report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $50.71.

Insider Buying and Selling

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average cost of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director now owns 2,000 shares in the company, valued at $87,940. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 3.07% of the company's stock.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.